WINFertilitySM, Inc. Expands Quality Discount Treatment Program for Infertility Patients to Northeast
New Yorkers who seek affordable, quality infertility care can now access unique program that includes both medical services AND infertility medications with discounts up to 50% for each treatment cycle.
White Plains, NY
November 17, 2011
WINFertility, Inc., the leader in Infertility Management Programs for insurers and employers, today announced the expansion of its consumer offering to the New York area. Building on the success of their recent program launch in the Southeast, Midwest and Northern Plains regions, the expansion is designed to increase the availability of affordable, advanced fertility care that remains financially out of reach for many of the half million New Yorkers facing infertility today who are without advanced infertility insurance coverage.
WINFertility has developed evidence-based treatment protocols for IUI, IVF and Third Party Reproduction, delivered by a contracted, credentialed network of fertility specialists. Infertility medications are included in the single, discounted, bundled price for Program participants. There is no age or medical criteria required to enroll in the Program. If treatment is indicated by a participating provider and the patient has no infertility insurance coverage, or has exhausted their benefit, she can enroll in the WINFertility Program. Typical patient savings per treatment cycle can range from $5,000 to $10,000 or more, depending on treatments and medication doses required.
The WINFertility approach is to promote high quality infertility care at the most competitive cost. Typical patient savings per treatment cycle can range from $5,000 to $10,000 or more, depending on treatments and medication doses required.
Incorporated in the unique Consumer Program is access to WINFertility’s FertilityCoach NursesSM on a 24/7 basis for education and care coordination, a Medical Advisory Board comprised of industry-leading Reproductive Endocrinologists and financing programs at preferred rates.
PROGRAM AVAILABILITY THROUGHOUT METROPOLITAN NY
Effective today, the WINFertility Quality Discount Treatment Program is available in greater New York through River View Fertility, in collaboration with Offices for Fertility and Reproductive Medicine (OFRM). Serving patients at their offices in Manhattan’s Financial District and Upper East Side, Brooklyn’s Park Slope and Nyack in Rockland County, River View Fertility/OFRM provides a full complement of infertility services, from testing and diagnosis, through IUI, IVF, Donor Programs and pre-implantation genetic diagnosis (PGD). “By combining the forces of our two practices, our intent is to expand access to personalized, high quality fertility treatment”, said Jesse Hade, MD and founder of River View Fertility. “The WINFertility Program is a perfect complement, enabling us to offer treatment and medications at a much more affordable price. Living in New York can be a challenge — this is a new way that we can give patients a financial break that is sorely needed in this economy”. Drs. Cecilia Schmidt-Sarosi and Peter Sarosi, founders of OFRM and acknowledged infertility pioneers commented, “Our goal is to help even the patients with the most challenging cases fulfill their dreams of parenthood. The absence of age or clinical qualifying criteria for the WINFertility Program will help us help more people become parents”.
MORE ACCESS for MORE PATIENTS
“The greater New York area has over 19 million people who call it home. It is very exciting to be able to expand the WINFertility footprint into one of the largest cities where so many struggle with infertility and its associated expenses”, announced Tom Boyajy, COO of WINFertility. “The WINFertility approach is to promote high quality infertility care at the most competitive cost. Our newest network physicians have earned reputations for both excellence in patient care and clinical results. Coupled with WIN’s proprietary treatment protocols, bundled packages, fertility management expertise, and our considerable buying power, we are confident that patients will receive the very best treatment value possible.”
“The response WIN has received about our Consumer Program has been very positive and has significantly surpassed expectations”, said Boyajy. “This encouraging reception is due to the compelling financial and clinical benefits of WIN’s offering that are unique in the marketplace. In order to meet market demand and provide greater program access to patients who require fertility help, we intend to accelerate our expansion timetable.”
Founded in 2000, WINFertility is the leader in Infertility Management Programs, annually managing infertility treatment for many thousands of infertility patients for major insurers and employers. WIN is leveraging their decade-long experience and clinical results in the fertility field, direct contracts with fellowship-trained fertility specialists, pharmaceutical manufacturers and national specialty pharmacies, to offer this unique direct-to-consumer program. Now, self-paying patients in Florida, Illinois, Minnesota and New York can enroll in the WINFertility Program and take advantage of WIN’s integrated platform to access to evidence-based protocols, quality providers and discounts enjoyed by the largest healthcare purchasers.